Singapore markets closed

Precision BioSciences, Inc. (DTIL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.1700+0.0100 (+0.86%)
At close: 04:00PM EST
1.2200 +0.05 (+4.27%)
After hours: 07:31PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 136.48M
Enterprise value -48.11M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)4.44
Price/book (mrq)1.62
Enterprise value/revenue -2.31
Enterprise value/EBITDA 0.50

Trading information

Stock price history

Beta (5Y monthly) 1.47
52-week change 3-75.47%
S&P500 52-week change 3-9.85%
52-week high 35.2000
52-week low 30.9500
50-day moving average 31.2601
200-day moving average 31.5353

Share statistics

Avg vol (3-month) 3582.21k
Avg vol (10-day) 3463.9k
Shares outstanding 5110.96M
Implied shares outstanding 6N/A
Float 886.21M
% held by insiders 117.04%
% held by institutions 147.57%
Shares short (12 Jan 2023) 4934.93k
Short ratio (12 Jan 2023) 41.36
Short % of float (12 Jan 2023) 40.88%
Short % of shares outstanding (12 Jan 2023) 40.84%
Shares short (prior month 14 Dec 2022) 41.14M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-530.87%

Management effectiveness

Return on assets (ttm)-27.72%
Return on equity (ttm)-113.48%

Income statement

Revenue (ttm)20.84M
Revenue per share (ttm)0.28
Quarterly revenue growth (yoy)-69.40%
Gross profit (ttm)115.53M
EBITDA -102.61M
Net income avi to common (ttm)-105.44M
Diluted EPS (ttm)-0.6700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)212.05M
Total cash per share (mrq)1.91
Total debt (mrq)27.46M
Total debt/equity (mrq)32.54
Current ratio (mrq)3.69
Book value per share (mrq)0.76

Cash flow statement

Operating cash flow (ttm)-47.59M
Levered free cash flow (ttm)-8.91M